Modern recommendations on diagnostics and treatment of lower extremity arteries diseases in the family doctors practice (review of the literature)

The aim of this review is to analyze current world achievements in the diagnosis and treatment of the lower extremity arteries diseases of (LEAD) in clinical practice.
Based on the analysis of literature data, an overview of placebo-controlled randomized clinical trials was performed, the results of which were included in the current European and American guidelines for the diagnosis and treatment of lower limb arteries (LEAD). Given the fact that the presence of LEAD significantly increases the risk of cardiovascular complications, modern international guidelines recommend that family doctors in the primary link carry out screening for the presence of LEAD by measuring the tibial – brachial index (AI recommendations class).
The results of many placebo-controlled randomized clinical studies indicate that cystaseol is much more effective than pentoxifylline and other drugs, it reduces the clinical manifestations of arterial blood flow disorders in the lower limbs, increases the maximum and painless walking distance and improves the quality of life of patients with LEAD, based on the recommendations of the latest 2016 The experts of the ANA / ACC (American Heart Association / American College of Cardiology) among all the drugs for the treatment of LEAD included only Cetazol for treatment of pathology of peripheral arteries (class of recommendations AI).

Key words: lower extremity arteries diseases, diagnosis, treatment, cilostazol, family medicine